| Net Cash Provided by (Used in) Operating Activities |
$36,612 |
USD |
-126348% |
Q1 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$34,554 |
USD |
5096% |
Q1 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$0 |
USD |
|
Q1 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
75,000,000 |
shares |
0% |
Q3 2025 |
Q3 2026 |
| Common Stock, Shares, Issued |
66,599,350 |
shares |
0.01% |
Q3 2025 |
Q3 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$8,460 |
USD |
356% |
Q3 2025 |
Q3 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q1 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$130,692 |
USD |
185% |
Q3 2025 |
Q3 2026 |
| Depreciation |
$105 |
USD |
0% |
Q1 2025 |
Q1 2026 |
| Property, Plant and Equipment, Gross |
$4,453 |
USD |
0% |
Q3 2025 |
Q3 2026 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$130,692 |
USD |
185% |
Q3 2025 |
Q3 2026 |
| Additional Paid in Capital |
$4,750 |
USD |
|
Q3 2025 |
Q3 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q3 2025 |
Q3 2026 |